These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
486 related articles for article (PubMed ID: 12588271)
1. Association of serum digoxin concentration and outcomes in patients with heart failure. Rathore SS; Curtis JP; Wang Y; Bristow MR; Krumholz HM JAMA; 2003 Feb; 289(7):871-8. PubMed ID: 12588271 [TBL] [Abstract][Full Text] [Related]
2. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Ahmed A; Rich MW; Love TE; Lloyd-Jones DM; Aban IB; Colucci WS; Adams KF; Gheorghiade M Eur Heart J; 2006 Jan; 27(2):178-86. PubMed ID: 16339157 [TBL] [Abstract][Full Text] [Related]
3. Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial. Ahmed A; Pitt B; Rahimtoola SH; Waagstein F; White M; Love TE; Braunwald E Int J Cardiol; 2008 Jan; 123(2):138-46. PubMed ID: 17382417 [TBL] [Abstract][Full Text] [Related]
4. Clinical benefits of low serum digoxin concentrations in heart failure. Adams KF; Gheorghiade M; Uretsky BF; Patterson JH; Schwartz TA; Young JB J Am Coll Cardiol; 2002 Mar; 39(6):946-53. PubMed ID: 11897434 [TBL] [Abstract][Full Text] [Related]
5. Dose response characterization of the association of serum digoxin concentration with mortality outcomes in the Digitalis Investigation Group trial. Adams KF; Butler J; Patterson JH; Gattis Stough W; Bauman JL; van Veldhuisen DJ; Schwartz TA; Sabbah H; Mackowiak JI; Ventura HO; Ghali JK Eur J Heart Fail; 2016 Aug; 18(8):1072-81. PubMed ID: 27492641 [TBL] [Abstract][Full Text] [Related]
6. Use of a simplified nomogram to individualize digoxin dosing versus standard dosing practices in patients with heart failure. DiDomenico RJ; Bress AP; Na-Thalang K; Tsao YY; Groo VL; Deyo KL; Patel SR; Bishop JR; Bauman JL Pharmacotherapy; 2014 Nov; 34(11):1121-31. PubMed ID: 25164709 [TBL] [Abstract][Full Text] [Related]
7. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis. Adams KF; Patterson JH; Gattis WA; O'Connor CM; Lee CR; Schwartz TA; Gheorghiade M J Am Coll Cardiol; 2005 Aug; 46(3):497-504. PubMed ID: 16053964 [TBL] [Abstract][Full Text] [Related]
8. Effect of digoxin noncompliance on hospitalization and mortality in patients with heart failure in long-term therapy: a prospective cohort study. Miura T; Kojima R; Mizutani M; Shiga Y; Takatsu F; Suzuki Y Eur J Clin Pharmacol; 2001 Apr; 57(1):77-83. PubMed ID: 11372597 [TBL] [Abstract][Full Text] [Related]
9. Serum digoxin concentration and outcomes in women with heart failure: A bi-directional effect and a possible effect modification by ejection fraction. Ahmed A; Aban IB; Weaver MT; Aronow WS; Fleg JL Eur J Heart Fail; 2006 Jun; 8(4):409-19. PubMed ID: 16311070 [TBL] [Abstract][Full Text] [Related]
10. Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations. Ahmed A J Gerontol A Biol Sci Med Sci; 2007 Mar; 62(3):323-9. PubMed ID: 17389731 [TBL] [Abstract][Full Text] [Related]
11. Sex-based differences in the effect of digoxin for the treatment of heart failure. Rathore SS; Wang Y; Krumholz HM N Engl J Med; 2002 Oct; 347(18):1403-11. PubMed ID: 12409542 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial. ; Ahmed A; Waagstein F; Pitt B; White M; Zannad F; Young JB; Rahimtoola SH Am J Cardiol; 2009 Jan; 103(1):82-7. PubMed ID: 19101235 [TBL] [Abstract][Full Text] [Related]
13. Assessment of the appropriateness of serum digoxin concentration measurement in a medical group setting. Orrico KB; Wu M; Wilson AR J Manag Care Pharm; 2011 Nov; 17(9):695-700. PubMed ID: 22050394 [TBL] [Abstract][Full Text] [Related]
14. Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Ahmed A; Rich MW; Fleg JL; Zile MR; Young JB; Kitzman DW; Love TE; Aronow WS; Adams KF; Gheorghiade M Circulation; 2006 Aug; 114(5):397-403. PubMed ID: 16864724 [TBL] [Abstract][Full Text] [Related]
16. Digoxin Benefit Varies by Risk of Heart Failure Hospitalization: Applying the Tufts MC HF Risk Model. Upshaw JN; van Klaveren D; Konstam MA; Kent DM Am J Med; 2018 Jun; 131(6):676-683.e2. PubMed ID: 29284111 [TBL] [Abstract][Full Text] [Related]
17. The impact of serum concentration-guided digoxin therapy on mortality of heart failure patients: A long-term follow-up, propensity-matched cohort study. Muk B; Vámos M; Bógyi P; Szabó B; Dékány M; Vágány D; Majoros Z; Borsányi T; Duray GZ; Kiss RG; Nyolczas N Clin Cardiol; 2020 Dec; 43(12):1641-1648. PubMed ID: 33140454 [TBL] [Abstract][Full Text] [Related]
18. [Digoxin: the results of the DIG study in the XXI century]. Helber I; Tucci PJ Arq Bras Cardiol; 2010 Oct; 95(4):e108-11. PubMed ID: 21180781 [TBL] [Abstract][Full Text] [Related]
19. The effect of digoxin on mortality and morbidity in patients with heart failure. Digitalis Investigation Group N Engl J Med; 1997 Feb; 336(8):525-33. PubMed ID: 9036306 [TBL] [Abstract][Full Text] [Related]
20. Effects of discontinuation of digoxin versus continuation at low serum digoxin concentrations in chronic heart failure. Ahmed A; Gambassi G; Weaver MT; Young JB; Wehrmacher WH; Rich MW Am J Cardiol; 2007 Jul; 100(2):280-4. PubMed ID: 17631083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]